Kimia Biosciences Share Price

BSE
49.69
+2.13 (4.17%)
KIMIABL • 13 Jun, 2025 | 03:30 PM
BUY

1Y Annualised Return

-15.30%

3Y Annualised Return

8.79%

5Y Annualised Return

14.93%

The current prices are delayed, login or Open Demat Account for live prices.

Kimia Biosciences SIP Return Calculator

Over the past

1 year
3 years
5 years

Total Investment of ₹65,00,000

Would have become ₹60,25,262 (-7.30%)

Daily SIP of 25,000 would have become 60,25,262 in 1 year with a gain of -4,74,737 (-7.30%)

Kimia Biosciences Stock Performance
Today’s Low - High
46.65
50.01
46.65
50.01
52 Week Low - High
35.10
58.39
35.10
58.39

Open

48.00

Prev. Close

47.56

Volume

5,103.00

Total Traded Value

2.54 L

View details of Market Depth
Kimia Biosciences Fundamental

Market Cap (in crs)

235.57

Face Value

1

Turnover (in lacs)

2.54

Key Metrics
Qtr Change %
41.85% Gain from 52W Low
8.2
Dividend yield 1yr %
0

Kimia Biosciences shareholding Pattern

Promoter
74.9%
Mutual Funds
0.4%
Domestic Institutions
0.4%
Public
24.7%
Promoter
74.9%
Mutual Funds
0.4%
Domestic Institutions
0.4%
Public
24.7%
Promoter
74.9%
Mutual Funds
0.4%
Domestic Institutions
0.4%
Public
24.7%
Promoter
74.9%
Mutual Funds
0.4%
Domestic Institutions
0.4%
Public
24.7%
Promoter
74.9%
Mutual Funds
0.4%
Domestic Institutions
0.4%
Public
24.7%
Promoter
74.9%
Mutual Funds
0.4%
Domestic Institutions
0.4%
Public
24.7%

Kimia Biosciences Technical Analysis

Moving Averages Analysis
Moving Averages Analysis
49.69
Current Price
Bullish Moving Averages
16
Bearish Moving Averages
0
5Day EMA
48.20
10Day EMA
47.80
12Day EMA
47.60
20Day EMA
46.60
26Day EMA
45.90
50Day EMA
44.70
100Day EMA
44.60
200Day EMA
45.30
5Day SMA
47.90
10Day SMA
47.90
20Day SMA
46.70
30Day SMA
44.20
50Day SMA
43.00
100Day SMA
44.00
150Day SMA
45.00
200Day SMA
46.40
Delivery & Volume

Delivery & Volume

PeriodCombined Delivery VolumeNSE+BSE Traded Volume
Day Rs
4051 Rs
5103 Rs
Week Rs
2460 Rs
3156 Rs
Month Rs
7422 Rs
9137 Rs
Resistance & Support
48.82
Pivot
Resistance
First Resistance
50.98
Second Resistance
52.18
Third Resistance
54.34
Support
First Support
47.62
Second support
45.46
Third Support
44.26
Relative Strength Index
60.27
Money Flow Index
43.44
MACD
1.65
MACD Signal
1.70
Average True Range
3.09
Average Directional Index
34.10
Rate of Change (21)
23.86
Rate of Change (125)
2.58

Kimia Biosciences Latest News

12 JUN 2025 | Thursday

Kimia Biosciences Ltd - 530313 - Revised Board Meeting Outcome Held On 26 May,2025 Document For The Quarter And Financial Year Ended On 31St March, 2025 (Regulation 30 And 33 Of The SEBI (Listing Obligations And Disclosure Requirements)Regulations, 2015

31 MAY 2025 | Saturday

Kimia Biosciences Ltd - 530313 - Announcement under Regulation 30 (LODR)-Newspaper Publication

29 MAY 2025 | Thursday

Kimia Biosciences Ltd - 530313 - Non-Applicability Of Regulation 24A Of SEBI(Listing Obligation And Disclosure ),Regulations,2015

View More

Kimia Biosciences Company background

Founded in: 1993
Kimia Biosciences Limited (Formerly known Laurel Organics Limited) was incorporated in September, 1993 led by the Promoters, A K Bansal, K S Varma, Atul Sharma, A P Godiyal, D K Gupta and R K Bansal. The Company has own manufacturing of Bulk DrugsAPIs at its plant located at Gurgaon, Haryana. The Company is engaged into the business of Pharamaceutical products.The company set up a bulk drug manufacturing unit at Gurgaon, Haryana, at a project cost of Rs 10.41 cr. It came out with a public issue in Feb.95 to partfinance the project. Commercial production commenced in May 95. During the 199899, the company has become a sick industrial units.The Honble BIFR vide order dated 27th December, 2005 had deregistered the Company as Sick Industrial Undertaking on the ground that 100% of the capacity was utilized for manufacture of the intermediate products for M/s Ranbaxy Laboratoty Limfted (RLL) and , thereby, turningout to be an ancillary industrial Undertaking. .The Honble AAIFR disposed the appeal of M/s Ranbaxy Lab. Ltd vide its Order dated 30.08.2006, directing them to file an application before the Hoble BIFR only to redress grievances. Therefore, M/s Ranbaxy Lab. Ltd had filed an applicationdated 31.10.06 before the Honble BIFR, requesting them to consider issuance of appropriate corrective orders. The Board has reconfirmed its earlier order. Therefore, despite negative net worth, the Company is out of BIFR purview.During the year 201718, the Scheme of Arrangement for Amalgamation of the Company with M/s Kimia Biosciences Limited was made effective from September 17, 2018. Upon Scheme of Amalgamation becoming effective on 17.09.2018, M/s. Kimia Biosciences Limited Holding Company having 37,28,100 Equity Shares (50.48%) of Rs. 10/ each of the Company got merged under reverse merger with the Company.

As of 13 Jun, 2025, KIMIABL share price is ₹49.8. The stock opened at ₹48 and had closed at ₹47.6 the previous day. During today’s trading session, KIMIABL share price moved between ₹46.65 and ₹50.01, with an average price for the day of ₹48.00. Over the last 52 weeks, the stock has recorded a low of ₹35.10 and a high of ₹58.39. In terms of performance, KIMIABL share price has increased by 4.7% over the past six months and has declined by 15.3% over the last year.

Read More

Kimia Biosciences FAQs

The Mutual Fund Shareholding in Kimia Biosciences was 0.38% at the end of 13/6/2025.

You can easily buy Kimia Biosciences shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.

Please be aware that Kimia Biosciences stock prices are subject to continuous fluctuations due to various factors.

Open Demat Account
+91 -

Open Demat Account
+91 -